Breaking news: Cialis gets FDA approved
Eli Lilly Corporation got their blockbuster impotence medication known as Cialis, FDA approved as treatment for enlarged prostates. This will directly affect the Eli Lilly Corporation as they now have a rival for Viagra. Sales are set to hit record levels now that Cialis got approved.
The impotence medication Cialis can now be considered for treatment of a non-cancerous enlarged prostate (also known as benign prostatic hyperplasia - BPH). The drug can also be used for people suffer from BPH and erectile dysfunction.
Recent studies have shown that almost 50 percent of men with ages over 50 years suffer from enlarged prostate problems. The most common effect of the enlargement of the prostate is having difficulties while urinating.
The news was confirmed by the FDA's director of the division of reproductive and urologic products Scott Monroe. He said that Cialis can help improve the quality of life for patients suffering from enlarged prostate as well as erectile dysfunction. This is good news as both problems are common for older men.
Cialis works the same way as its competitors Viagra and Levitra but what makes it better than the others is the duration of its effect. While Levitra and Viagra last for approximately 5 hours, Cialis lasts for 17 hours and thus giving it its famous nickname, "the weekend pill". Although Cialis was the last of the three erectile dysfunction drugs to hit the market back in 2003 it generated important amounts of revenue partly because it is the only one of the three that can be offered as a daily medication and partly because of its long time effect.
Tadalafil is the original name for Cialis and it works with the help of PDE5 inhibitor. The PDE5 inhibitor works by relaxing the muscular walls of the arteries and thus dilates the blood vessels. In the case of pulmonary arterial hypertension the drug goes by the name Adcirca.
Now that Cialis has been made available for the general public as treatment for enlarged prostate patients, doctors will have more options when choosing to prescribe a treatment.
